{"id":"tp-40597","type":"article-newspaper","title":"AstraZeneca Says Experimental Stomach Cancer Drug Doubled Survival","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/40597","datePublished":"2026-10-25T16:30:01.000Z","dateModified":"2026-10-25T16:30:01.000Z","language":"en","abstract":"The company identified sonesitatug vedotin as the experimental treatment in a late-stage study.","section":"Business","references":[]}